Healthware Group

Healthware Group is now part of EVERSANA INTOUCH as a full-service agency affiliate combining innovation with global strategy and capabilities to build the future of health. Follow us EVERSANA INTOUCH and read the press release to learn more. https://www.eversana.com/2024/04/15/eversana-completes-integration-of-healthware-group-and-strengthens-its-global-agency-network-eversana-intouch-with-addition-of-new-full-service-affiliate/

Discover the insights from our Managing Director, Digital Health & Innovation, Alberta M.C. Spreafico, PhD, MBA, in EVERSANA’s article focused on the challenges faced by manufacturers of software as a medical device (SaMD) following the implementation of Regulation (EU) 2017/745, known as the Medical Device Regulation (MDR).

Alberta Spreafico, along with co-authors Gwilym Owen and Kory Dillman, sheds light on the loophole that allowed SaMD to be misclassified under the previous Medical Device Directive ( ) and the implications of this misclassification under the MDR.

Learn more about the challenges and solutions in the article: https://www.eversana.com/insights/the-looming-legacy-of-software-as-a-medical-device-samd-misclassification-under-medical-device-directive-mdd/



EVERSANA INTOUCH

pharmaphorum’s Deep Dive R&D 2024 is here, packed with insights on CRISPR technology, AI, innovation in rare diseases, and the modernization of clinical trials.

🔬From attention to detail in clinical supply management to sustainability in pharma, this issue delves into the key topics shaping the future of R&D in pharma.

Discover more 📗 https://deep-dive.pharmaphorum.com/magazine/research-and-development-2024/research-development-2024/

Get the latest pharma news straight to your inbox. Sign up for pharmaphorum's newsletter: https://pharmaphorum.com/register

Research and Development 2024 - pharmaphorum Deep Dive – R&D 2024 features interviews, analysis, and commentary from pharmaphorum, Alexion, Samsung Biologics, JP Morgan, UCB, Clinigen, and more